BiotechTV

•

Kanal • 5 Sendungen

Biowissenschaften

Biowissenschaften

Zweiwöchentlich
Biowissenschaften

Biowissenschaften

19.12.2025
Biowissenschaften

Biowissenschaften

vor 3 Std.
Biowissenschaften

Biowissenschaften

08.05.2025
Biowissenschaften

Biowissenschaften

2. Feb.

11. JAN.

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

11. Jan.

•

1 Std. 15 Min.
9. FEB.

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

9. Feb.

•

1 Std. 7 Min.
18.12.2024

Episode 8: Canaan Partners' Julie Grant

A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.

18.12.2024

•

1 Std. 8 Min.
02.12.2024

Episode 7: MPM BioImpact's Ansbert Gadicke

MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment collaborators. Plus, the keys making it through a down cycle like the industry has been in over recent years.

02.12.2024

•

1 Std. 11 Min.
26. JAN.

Episode 33: Pappas Capital's Art Pappas

Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.

26. Jan.

•

58 Min.
04.11.2024

Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary

He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.

04.11.2024

•

1 Std. 4 Min.
10.03.2025

Episode 14: Aditum Bio's Joe Jimenez

Joe Jimenez describes the career path in consumer products that led him to pharma, his time running Novartis, and the idea to co-found Aditum Bio with his partner Mark Fishman. He explains Aditum's investment philosophy, and why they like focusing on translational medicine opportunities that are just heading into the clinic. Plus, his thoughts on making R&D more efficient.

10.03.2025

•

1 Std. 13 Min.
06.10.2025

Episode 26: venBio's Corey Goodman

Corey Goodman shares learnings for his career in biotech, including working in academia, biotech, pharma, and as a venture capital investor. He describes the unique learnings from all of them and why he is thankful that he has experienced these different components of life sciences.

06.10.2025

•

1 Std. 21 Min.
22.07.2025

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

He describes data that Mestera presented at ADA for its monthly-dosed GLP1 and also its amylin analog. Plus, recent learnings about the field in general, including what orforglipron might mean for the oral therapy space and why Metsera believes in an oral peptide.

22.07.2025

•

18 Min.
17.07.2025

Prime Medicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline

He describes the benefits of prime editing, walks us through human proof-of-concept data that was announced in a patient with Chronic Granulomatous Disease, and explains the rationale to focus on Wilson's Disease, Alpha-1 Antitrypsin Deficiency, Cystic Fibrosis, and the company's CAR-T partnership with Bristol Myers Squibb.

17.07.2025

•

25 Min.

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Channel Website

BiotechTV

Top-Sendungen

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 34: General Atlantic's Brett Zbar

Episode 8: Canaan Partners' Julie Grant

Episode 7: MPM BioImpact's Ansbert Gadicke

Episode 33: Pappas Capital's Art Pappas

Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary

Episode 14: Aditum Bio's Joe Jimenez

Episode 26: venBio's Corey Goodman

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

Prime Medicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline

Info

BiotechTV

Top-Sendungen

Top-Folgen

Info